Literature DB >> 33345832

Molybdenum-based hetero-nanocomposites for cancer therapy, diagnosis and biosensing application: Current advancement and future breakthroughs.

Namdev Dhas1, Ritu Kudarha2, Atul Garkal1, Vivek Ghate3, Shilpa Sharma4, Prabhakar Panzade5, Shubham Khot6, Pinal Chaudhari3, Ashutosh Singh7, Mitali Paryani1, Shaila Lewis3, Neha Garg8, Narinder Singh4, Priyanka Bangar9, Tejal Mehta10.   

Abstract

In recent years, there have been significant advancements in the nanotechnology for cancer therapy. Even though molybdenum disulphide (MoS2)-based nanocomposites demonstrated extensive applications in biosensing, bioimaging, phototherapy, the review article focusing on MoS2 nanocomposite platform has not been accounted for yet. The review summarizes recent strategies on design and fabrication of MoS2-based nanocomposites and their modulated properties in cancer treatment. The review also discussed several therapeutic strategies (photothermal, photodynamic, immunotherapy, gene therapy and chemotherapy) and their combinations for efficient cancer therapy along with certain case studies. The review also inculcates various diagnostic techniques viz. magnetic resonance imaging, computed tomography, photoacoustic imaging and fluorescence imaging for diagnosis of cancer.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomedical applications; Chemotherapy; Magnetic resonance imaging; Molybdenum disulphide; Photoacoustic imaging; Phototherapy

Year:  2020        PMID： 33345832     DOI： 10.1016/j.jconrel.2020.12.015

Source DB:  PubMed          Journal:  J Control Release        ISSN： 0168-3659            Impact factor:   9.776


  6 in total

1.  A molybdenum oxide-based degradable nanosheet for combined chemo-photothermal therapy to improve tumor immunosuppression and suppress distant tumors and lung metastases.

Authors:  Na Qiu; Xiaoye Yang; Yanan Zhang; Jicheng Zhang; Jianbo Ji; Yu Zhang; Xinru Kong; Yanwei Xi; Dongzhu Liu; Lei Ye; Guangxi Zhai
Journal:  J Nanobiotechnology       Date:  2021-12-19       Impact factor: 10.435

Review 2.  Recent Advance of Nanomaterial-Mediated Tumor Therapies in the Past Five Years.

Authors:  Xinyan Hao; Junyong Wu; DaXiong Xiang; Yongyu Yang
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

3.  Docetaxel-Loaded Novel Nano-Platform for Synergistic Therapy of Non-Small Cell Lung Cancer.

Authors:  Xing Feng; Xiaoling Xiong; Shenglin Ma
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.988

Review 4.  Research Progress of Photothermal Nanomaterials in Multimodal Tumor Therapy.

Authors:  Xiaolu Shi; Ye Tian; Yang Liu; Zhengrong Xiong; Shaobo Zhai; Shunli Chu; Fengxiang Gao
Journal:  Front Oncol       Date:  2022-07-06       Impact factor: 5.738

5.  Association between urinary metals and leukocyte telomere length involving an artificial neural network prediction: Findings based on NHANES 1999-2002.

Authors:  Fang Xia; Qingwen Li; Xin Luo; Jinyi Wu
Journal:  Front Public Health       Date:  2022-09-12

Review 6.  Carbon Dots: A Future Blood-Brain Barrier Penetrating Nanomedicine and Drug Nanocarrier.

Authors:  Wei Zhang; Ganesh Sigdel; Keenan J Mintz; Elif S Seven; Yiqun Zhou; Chunyu Wang; Roger M Leblanc
Journal:  Int J Nanomedicine       Date:  2021-07-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.